Zolaren Plus(Brinzolamide 1% & Brimonidine Tartrate 0.2)

Therapeutic Group: Ophthalmic Presentation Zolamid Plus Sterile Ophthalmic Suspension: Each ml contains Brinzolamide USP 10 mg and Brimonidine Tartrate BP 2 mg. Description Zolamid Plus is a combination of a carbonic anhydrase inhibitor, brinzolamide and an alpha 2 adrenergic receptor agonist, brimonidine tartrate. Each of these two components decreases elevated intraocular pressure. Brinzolamide inhibits carbonic […]

Zolaren Ophthalmic Suspension(Brinzolamide 1%)

Therapeutic Group: Ophthalmic Presentation Zolamid Sterile Ophthalmic Suspension: Each ml contains Brinzolamide USP 10 mg Description Brinzolamide is a carbonic anhydrase II (CA-II) inhibitor that inhibits aqueous humor production to reduce elevated intraocular pressure. Indications Zolamid Sterile Ophthalmic Suspension is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle […]

Brimodin Plus(Brimonidine Tartrate 0.2% & Timolol 0.5%)

Therapeutic Group: Anti Glaucoma Presentation Brimodin Plus Sterile Eye Drops: Each ml contains Brimonidine Tartrate INN 2 mg and Timolol Maleate USP equivalent to Timolol 5 mg. Description Brimodin Plus is a combination preparation of selective alpha-2 adrenergic receptor agonist, brimonidine and a non-selective beta-adrenergic receptor inhibitor, timolol. Fluorophotometric studies in animals and humans suggest […]

Brimodin Eye Drops(Brimonidine Tartrate 0.2% )

Therapeutic Group: Ophthalmic- Antiglaucoma Presentation Each ml contains Brimonidine Tartrate INN 2 mg. Description Brimodin contains the active ingredient brimonidine. It is a relatively selective alpha-2 adrenergic receptor agonist and approximately 1000 times more selective for the alpha-2 adrenoceptor than the alpha-1 adrenoceptor. Topical administration of brimonidine decreases intraocular pressure (IOP) in humans. When used […]

Brigacent(Brigatinib)

Therapeutic Group: Anti Cancer Presentation Brigacent 90: Each film coated tablet contains Brigatinib INN 90 mg. Brigacent 180: Each film coated tablet contains Brigatinib INN 180 mg. Description Brigatinib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor that blocks both anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR). Indications Brigatinib is […]

Mestiza 40(Black cohosh)

Therapeutic Group: Herbal and Nutraceuticals Presentation Each capsule contains 40 mg Black cohosh. Description Black cohosh is an herb and the root of this herb is used for medicinal purposes. The active ingredients in the root are the triterpine glycosides. Black cohosh is commonly used to treat symptoms of menopause, premenstrual syndrome (PMS) and painful […]

Bisopro-A(Bisoprolol Fumarate 2.5 mg & Amlodipine 5 mg)

Therapeutic Group: Cardiovascular Presentation Bisopro-ATM 2.5/5: Each tablet contains Bisoprolol Fumarate USP 2.5 mg & Amlodipine Besilate BP equivalent to Amlodipine 5 mg. Description Amlodipine is a Dihydropyridine Calcium antagonist that inhibits the transmembrane influx of Calcium ions into cardiac and vascular smooth muscle. It has greater affinity towards vascular smooth muscle than on cardiac […]

Bisopro Plus(Bisoprolol fumarate + Hydrochlorothiazide)

Therapeutic Group: Cardiovascular Presentation Bisopro 2.5 Plus: Each tablet contains Bisoprolol fumarate USP 2.5 mg and Hydrochlorothiazide BP 6.25 mg Bisopro 5 Plus: Each tablet contains Bisoprolol fumarate USP 5 mg and Hydrochlorothiazide BP 6.25 mg Description Bisoprolol is a beta1 selective (cardio selective) adrenoceptor blocking agent without significant membrane stabilizing activity or intrinsic sympathomimetic […]

Bisopro(Bisoprolol)

Therapeutic Group: Cardiovascular Presentation Bisopro 2.5 : Each tablet contains Bisoprolol Fumarate USP 2.5 mg. Bisopro 5 : Each tablet contains Bisoprolol Fumarate USP 5 mg. Description Bisoprolol is a beta1-selective (cardioselective) adrenoceptor blocking agent without significant membrane stabilizing activity or intrinsic sympathomimetic activity in its therapeutic dosage range. Indications Bisoprolol is indicated in the […]

Peptocid(Bismuth Subsalicylate)

Therapeutic Group: Gastro Intestinal Disorders Presentation Peptocid Suspension: Each 30 ml contains 525.6 mg Bismuth Subsalicylate BP. Description Antacid action: Peptocid coats ulcer surface, protecting it from acid and pepsin. It stimulates mucus and bicarbonate secretion and also reacts with HCl, producing bismuth oxychloride and salicylic acid. Thus it reduces HCl. Anti-diarrheal action: Bismuth Subsalicylate […]